Tumour cells can evade immune surveillance by the expression of programmed death-ligand 1 (PD-L1), which interacts with programmed death-1 (PD-1) receptor on T cells to elicit the immunosuppressive response [159]. The gene discussed is CD274; the disease is neoplasm.